Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Bayer Subside Monsanto India appoints Cherukuri Ravishankar as new MD

      Bayer Subside Monsanto India appoints Cherukuri Ravishankar as new MD

      Medical Dialogues Bureau25 Sept 2018 9:00 AM IST
      New Delhi: Seed firm Monsanto India, a subsidiary of Bayer group, has recently announced the appointment of Cherukuri Ravishankar as the Managing...
      Japan provides medical equipment worth Rs 1 billion

      Japan provides medical equipment worth Rs 1 billion

      Medical Dialogues Bureau25 Sept 2018 9:00 AM IST
      JICA had provided support for construction of physical infrastructure and medical equipment to TUTH in 1983 for the first time and in 1992 for the...
      Gufic Biosciences board approves amalgamation with Gufic Lifesciences

      Gufic Biosciences board approves amalgamation with Gufic Lifesciences

      Medical Dialogues Bureau24 Sept 2018 4:43 PM IST
      New Delhi: Gufic Bioscience has recently announced that board has approved the scheme of amalgamation of Gufic Lifesciences with the company, in a...
      AMD Drug: British Doctors Win; Novartis, Bayer, Roche Lose

      AMD Drug: British Doctors Win; Novartis, Bayer, Roche Lose

      Medical Dialogues Bureau24 Sept 2018 2:08 PM IST
      ZURICH: Drug giants Novartis, Bayer and Roche have recently lost a bid to stop British doctors from recommending a cheaper drug option for people with...
      Medical Device Companies will have to give compensation in case of adverse event: Govt proposes provision in law

      Medical Device Companies will have to give compensation in case of adverse event: Govt proposes provision in law

      Medical Dialogues Bureau24 Sept 2018 1:03 PM IST
      The move comes after complaints that patients had suffered due to faulty hip implants by a subsidiary of pharma giant Johnson and Johnson. New Delhi:...
      Wrong Labelling: Intas Pharma US arm recalls over 46,000 bottles of diuretic drug

      Wrong Labelling: Intas Pharma US arm recalls over 46,000 bottles of diuretic drug

      Medical Dialogues Bureau24 Sept 2018 12:38 PM IST
      Accord Healthcare recall is based on "Labelling: label mix-up: customer complaint that a sealed bottle labelled as Hydrochlorothiazide tablets USP...
      Bayer says Monsanto India integration to complete in one year

      Bayer says Monsanto India integration to complete in one year

      Medical Dialogues Bureau24 Sept 2018 9:00 AM IST
      Bayer completed the USD 63 billion mega-deal to acquire US-based Monsanto to create the world's biggest agrochemical and seed company. New Delhi: It...
      DOP rejects Review Petition of Lupin against ceiling price fixation for its combinations

      DOP rejects Review Petition of Lupin against ceiling price fixation for its combinations

      Medical Dialogues Bureau23 Sept 2018 12:39 PM IST
      Department of Pharmaceutical rejected the review petition of Lupin " Lupin has not implemented the price notification"New Delhi: Through a recent...
      CDSCO launches blood products module under SUGAM

      CDSCO launches blood products module under SUGAM

      Medical Dialogues Bureau23 Sept 2018 10:15 AM IST
      New Delhi: Through a recent notice Ministry of Health & Family Welfare, Director General of Health Services, Central Drugs Standard Control...
      Inventia Healthcare files Rs 450-cr IPO papers with SEBI

      Inventia Healthcare files Rs 450-cr IPO papers with SEBI

      Medical Dialogues Bureau23 Sept 2018 10:00 AM IST
      NEW DELHI: Inventia Healthcare has filed draft papers with capital markets regulator SEBI to raise an estimated Rs 450 crore through an initial public...
      Swiss medtech firm Implantica plans stock market listing

      Swiss medtech firm Implantica plans stock market listing

      Medical Dialogues Bureau23 Sept 2018 9:33 AM IST
      Implantica regularly reviews available financing alternatives to finance the commercialization of its first implant, RefluxStop, and to accelerate the...
      Mylan, Biocon bag Positive CHMP opinion for pegfilgrastim biosimilar, Fulphila

      Mylan, Biocon bag Positive CHMP opinion for pegfilgrastim biosimilar, Fulphila

      Medical Dialogues Bureau23 Sept 2018 9:00 AM IST
      Biocon and pharma firm Mylan said CHMP has a positive opinion recommending approval for their pegfilgrastim biosimilar, Fulphila.New Delhi:...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok